openPR Logo
Press release

Precision in Pharmaceutical Analysis: Resmetirom Impurity Standards from AquigenBio

08-11-2025 03:12 PM CET | Chemicals & Materials

Press release from: Aquigen Bio Sciences

Resmetirom Impurity Standards from AquigenBio

Resmetirom Impurity Standards from AquigenBio

Resmetirom is a breakthrough thyroid hormone receptor-β agonist, currently under investigation for the treatment of nonalcoholic steatohepatitis (NASH). The successful development, validation, and filing of Resmetirom-based therapies require precision in impurity profiling - a critical cornerstone of global regulatory acceptance.

Why Choose AquigenBio's Resmetirom Impurities?
1. High-Purity Reference Standards: Each impurity is synthesized and purified to >95% purity, with robust documentation including HPLC, MS, and NMR characterization data for your quality assurance.

2. Regulatory Readiness: All products are crafted to support compliance with FDA, EMA, and ICH guidelines. They are essential for AMV, ANDA, DMF, and NDA submissions, helping you meet impurity identification thresholds and avoid regulatory bottlenecks.

3. Quick Turnaround & Reliable Supply: AquigenBio's impurities are available for immediate dispatch, minimizing delays in analytical projects and regulatory filings.

4. Custom Synthesis & Isotopic Standards: Whether you need unique impurities or stable isotope-labeled standards for cutting-edge LC-MS assays, AquigenBio offers custom synthesis on request - ensuring your analytical needs are fully met.

5. Certificate of Analysis & Traceability: Each batch is accompanied by a comprehensive Certificate of Analysis (CoA), meeting regulatory expectations and supporting audits.

Key Applications
- Analytical method development & validation
- Impurity profiling and quantification
- Quality control for batch release
- Stability studies and toxicological assessments
- Regulatory submissions and dossier filings

Featured Impurities & Standards

AquigenBio's range includes:

- Resmetirom Impurity 10 (CAS 1581304-50-8): Enables method validation, impurity identification, and QC.

- Isotopically labeled Resmetirom standards (e.g. 13C3 15N): Ideal for advanced bioanalytical LC-MS assays, supporting robust pharmacokinetic studies.

- Additional Resmetirom impurities for comprehensive profiling - all supplied with in-depth analytical data.

Empower Your Research and Compliance Journey
With the global pharma landscape shifting rapidly toward metabolic and liver disease solutions, access to validated impurity standards is non-negotiable. AquigenBio delivers the foundation you need for regulatory confidence, analytical precision, and accelerated product development.

Contact AquigenBio Today to request a quote or discuss custom impurity solutions. Benefit from industry-leading quality, rapid fulfillment, and expert support - all designed to maximize your research impact and unlock successful regulatory filings.

Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Visit: www.aquigenbio.com

AquigenBio's Commitment to Excellence

With a mission to bridge the gap between analytical needs and high-quality reference materials, AquigenBio continues to invest in research, quality assurance, and global supply chain efficiency. All products undergo stringent ISO-compliant quality checks before shipment, ensuring that customers receive only the highest purity standards.

Aquigen Bio is a leading provider of certified reference standards, impurity profiling compounds, and research chemicals to pharma, biotech, and academic institutions worldwide. With a dedication to excellence and a focus on regulatory readiness, Aquigen empowers scientists to innovate with confidence.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Precision in Pharmaceutical Analysis: Resmetirom Impurity Standards from AquigenBio here

News-ID: 4140187 • Views:

More Releases from Aquigen Bio Sciences

AquigenBio Expands Ibuprofen Impurity Standards Portfolio for Advanced Pharmaceutical Testing
AquigenBio Expands Ibuprofen Impurity Standards Portfolio for Advanced Pharmaceu …
AquigenBio, a trusted global provider of high-quality impurity standards and reference materials, has announced the expansion of its Ibuprofen Impurity Standards portfolio. These new offerings are designed to meet the growing demand for precise analytical tools in pharmaceutical research, quality control, and regulatory compliance. The updated category now includes specialized impurity standards for Ibuprofen and its related compounds, delivering high-purity reference materials that meet stringent industry and regulatory requirements. Newly Featured Ibuprofen
Lactitol Impurity Standards for High-Precision Pharmaceutical Analysis | Aquigen Bio
Lactitol Impurity Standards for High-Precision Pharmaceutical Analysis | Aquigen …
In today's highly regulated pharmaceutical landscape, accurate impurity profiling plays a critical role in ensuring drug safety and compliance. For analysts working with Lactitol, having access to reliable, pharmacopeial-grade impurity standards is essential for developing robust analytical methods and maintaining batch-to-batch consistency. Aquigen Bio offers high-purity Lactitol impurity standards, fully characterized and ready to support your analytical and regulatory workflows. Why Lactitol Impurity Standards Are Important Lactitol is a sugar alcohol used in
Aquigen Bio Introduces N‐Nitroso Pirfenidone EP Impurity B - A High-Purity Reference Standard for Pharmaceutical Analysis, Method Validation, and Regulatory Compliance in Pirfenidone Impurity Profiling
Aquigen Bio Introduces N‐Nitroso Pirfenidone EP Impurity B - A High-Purity Ref …
Pune-/Delran- Aquigen Bio is pleased to announce the introduction of N‐Nitroso Pirfenidone EP Impurity B, a premium reference standard designed for the highest rigor in pharmaceutical analysis and regulatory compliance. Available via custom‐synthesis, this product serves as an essential resource for analytical method development (AMD), method validation (AMV), quality control (QC), and support for Abbreviated New Drug Applications (ANDA) https://aquigenbio.com/product/n-nitroso-pirfenidone-ep-impurity-b/ Product Highlights Name: N‐Nitroso Pirfenidone EP Impurity B Catalog No: AQ‐N000968 CAS No: 2512237‐43‐1 Molecular
Aquigen Bio Expands its Impurity Standards Portfolio with Malathion & Dithiodisuccinate Reference Materials
Aquigen Bio Expands its Impurity Standards Portfolio with Malathion & Dithiodisu …
Aquigen Bio Sciences, a leading pharmaceutical impurity‐standards manufacturer based in India, continues to broaden its catalog with new high‐quality analytical reference standards. These include Malathion EP Impurity A, O,O‐Dimethyl Malathion, and Tetraethyl Dithiodisuccinate, designed to support rigorous research, validation, and regulatory compliance in agrochemical and pharmaceutical analysis. Introducing New Additions to the Impurity Standards Line-up https://aquigenbio.com/product/tetraethyl-dithiodisuccinate/ Malathion EP Impurity A This compound-diethyl (2R)-2‐((methoxy(methylthio)phosphoryl)thio)succinate-offers traceability to pharmacopeial standards, such as USP or EP. It is

All 5 Releases


More Releases for AquigenBio

Aquigen Bio Introduces N‐Nitroso Pirfenidone EP Impurity B - A High-Purity Ref …
Pune-/Delran- Aquigen Bio is pleased to announce the introduction of N‐Nitroso Pirfenidone EP Impurity B, a premium reference standard designed for the highest rigor in pharmaceutical analysis and regulatory compliance. Available via custom‐synthesis, this product serves as an essential resource for analytical method development (AMD), method validation (AMV), quality control (QC), and support for Abbreviated New Drug Applications (ANDA) https://aquigenbio.com/product/n-nitroso-pirfenidone-ep-impurity-b/ Product Highlights Name: N‐Nitroso Pirfenidone EP Impurity B Catalog No: AQ‐N000968 CAS No: 2512237‐43‐1 Molecular
AquigenBio Launches High-Purity EP Impurity Standards for Propylthiouracil, Incl …
AquigenBio is pleased to announce the availability of two essential impurity reference standards-Propylthiouracil EP Impurity A and Propylthiouracil EP Impurity B. These impurity standards are now available to support pharmaceutical companies, contract research organizations, and analytical laboratories engaged in drug development, quality control, and regulatory compliance. Propylthiouracil (PTU) is a well-known antithyroid medication, widely used in the treatment of hyperthyroidism. In line with pharmacopeial guidelines, it is critical to identify and
Unveiling Tegoprazan Impurity 2: A Critical Reference Standard in P-CAB Drug Dev …
As the pharmaceutical industry advances toward next-generation acid suppression therapies, potassium-competitive acid blockers (P-CABs) like Tegoprazan are emerging as game changers in the treatment of gastroesophageal reflux disease (GERD) and other acid-related conditions. However, to ensure the safety, efficacy, and regulatory compliance of P-CAB-based drugs, identifying and monitoring impurities during synthesis and storage is non-negotiable. Explore Tegoprazan Category https://aquigenbio.com/products/impurity-standards/tegoprazan/ One such critical impurity is Tegoprazan Impurity 2 - a process-related compound now available
Exploring Key Dabigatran Derivatives: A Closer Look at N-Methoxycarbonyl and O-A …
Dabigatran is a well-established direct thrombin inhibitor used primarily in anticoagulation therapy to prevent stroke and treat deep vein thrombosis or pulmonary embolism. As with many active pharmaceutical ingredients (APIs), the analysis and synthesis of its related substances-particularly esterified and modified forms-play a crucial role in pharmaceutical research, formulation development, and regulatory compliance. This article delves into four important derivatives of Dabigatran: N-Methoxycarbonyl Dabigatran Ethyl Ester O-(3-Hexyl) Dabigatran Ethyl Ester O-Butyl Dabigatran Ethyl Ester O-Desethyl
Evolving Market Trends In The Autacoids And Related Drug Industry: Improving Acc …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics._x000D_ _x000D_ What Is the Expected Autacoids And Related Drug Market Size During the Forecast Period?_x000D_ There has been a remarkable growth in the market size of autacoids and analogous drugs in the previous years. It is set to escalate from $50.15 billion in 2024 to $53.32 billion in 2025, portraying a compound annual growth
AquigenBio Advances Oncology Research with High-Purity Gefitinib and Certified I …
Pune, India - May 9, 2025 - AquigenBio, a leading provider of high-quality impurity standards, is proud to announce the expansion of its product portfolio with the addition of certified impurity standards for Gefitinib. These standards are essential for the pharmaceutical industry, particularly for developers of generic formulations, to ensure the safety, efficacy, and regulatory compliance of their products. Introduction to Gefitinib and Its Importance in Oncology https://aquigenbio.com/products/impurity-standards/gefitinib/ Gefitinib, marketed under the brand